A type II latency program, which includes the expression of latent membrane proteins 1 and 2 (LMP1 and LMP2), EBV nuclear antigen 1 (EBNA1) and EBV-encoded RNAs (EBERs), is often operating in EBV-infected NPC cells [1]. This evidence concerns the gene PDLIM7 and nasopharyngeal carcinoma.